COMBINATION THERAPY FOR ARTERIAL HYPERTENSION: REALITIES OF CLINICAL PRACTICE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

40% of the inhabitants of our country suffer from arterial hypertension. Fixed-dose combination antihypertensive drugs allow the cardiovascular risk to be reduced (by 20-25% for myocardial infarction, 50% for heart failure, and 35-40% for stroke).

Full Text

Restricted Access

About the authors

M. Lutoshkin

Vologda Town Hospital One

Email: lutoshkin35@mail.ru
Candidate of Medical Sciences

E. Smirnova

Vologda Town Hospital One

O. Kuzmenko

Vologda Town Hospital One

I. Ryukhina

Vologda Town Hospital One

References

  1. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension // J. Hypertens. - 2007; 25: 1105-87.
  2. Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Диагностика и лечение артериальной гипертензии. Российские рекомендации (4-й пересм.) // Системные гипертензии. - 2010; 3: 5-26.
  3. Mancia G., Laurent S., Agabiri-Rosei Е. et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document // J. Hypertens. - 2009; 27: 2121-58.
  4. Jamerson K. et al. Benazepril plus Amlodipine or hydrochlorothiazide for Hypertension in High-Risk Patients // N. Engl. J. Med. - 2008; 359: 2417-28.
  5. Dolan E., Stanton А., Parker K. et al. On behalh of the ASCOT Investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients. ASCOT substudy // J. Hypertens. - 2009; 27: 876-85.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies